Imagen de Portada

How can Alzheimer's disease blood‐based biomarkers reach clinical practice?

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Robert Perneczky, Frances‐Catherine Quevenco, James Hendrix, Stephane Epelbaum, Charlotte Teunissen, Wiesje M. van der Flier, Marc Suárez‐Calvet, Jiong Shi, Michelle M. Mielke, Takeshi Iwatsubo, Sebastian Palmqvist, Oskar Hansson
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
por: Thomas Claessen, et al.
Publicado: (2025)

Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease
por: Katharina Bolsewig, et al.
Publicado: (2024)

Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting
por: Steffi De Meyer, et al.
Publicado: (2025)

Amyloid‐related changes in fluency in patients with subjective cognitive decline
por: Rosanne L. van den Berg, et al.
Publicado: (2025)

Performance of plasma p‐tau217 and NfL in an unselected memory clinic setting
por: Rebecca Z. Rousset, et al.
Publicado: (2024)

Response to the letter to the editor “Blood‐based biomarkers for Alzheimer's disease in primary care: A French qualitative study exploring perspectives of general practitioners”
por: Thomas Claessen, et al.
Publicado: (2026)

Survey among experts on the future role of tau‐PET in clinical practice and trials
por: Marie R. Vermeiren, et al.
Publicado: (2024)

Clinical utility of CSF Aβ38 in Japanese research and clinical cohorts
por: Tamao Tsukie, et al.
Publicado: (2025)

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia
por: Iolanda Lázaro, et al.
Publicado: (2024)

The relationship between cognitive screeners and everyday functioning in amyloid‐positive participants from the Amsterdam Dementia Cohort
por: Angela van der Putten‐Toorenburg, et al.
Publicado: (2026)

Application of machine learning to blood‐based biomarkers of Alzheimer's disease in Down syndrome
por: Patrick H. Luckett, et al.
Publicado: (2026)

Clinical performance of scalable automated p‐tau 217 multi‐analyte algorithmic blood test with reduced intermediate zone using multiplexed digital immunoassay
por: David H. Wilson, et al.
Publicado: (2025)

Interchangeability of CSF and PET to identify Alzheimer's disease pathology
por: Samantha C. Burnham, et al.
Publicado: (2026)

Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry‐based proteomics
por: Marijke E. Stokkel, et al.
Publicado: (2026)

Web‐based LAS‐FNAME and blood biomarkers in autosomal dominant Alzheimer's disease
por: Christopher Gonzalez Corona, et al.
Publicado: (2026)

ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes
por: Luciana Mascarenhas Fonseca, et al.
Publicado: (2024)

Opportunities to encourage adoption of a biomarker‐enabled care pathway for Alzheimer's in primary care
por: Soo Borson, et al.
Publicado: (2025)

Changes in Alzheimer's disease blood biomarkers in kidney failure before and after kidney transplant
por: Anneka E. Blankenship, et al.
Publicado: (2024)

Impact of COVID‐19 pandemic on mortality rate in memory clinic patients
por: Els D. Bakker, et al.
Publicado: (2024)

Long‐term cost‐effectiveness of a more accurate diagnostic work‐up for dementia
por: Pieter J. van der Veere, et al.
Publicado: (2025)

Blood biomarkers for Alzheimer's disease: Reliable change and impacts of renal and blood–brain barrier function
por: Anders Behrens, et al.
Publicado: (2025)

Sex‐specific blood biomarkers linked to memory changes in middle‐aged adults: The Framingham Heart Study
por: Huitong Ding, et al.
Publicado: (2024)

Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire
por: Ayesha Fawad, et al.
Publicado: (2026)

Ethics of disclosure of onset‐predictive biomarker test results for genetic frontotemporal dementia in the research context
por: Charlotte H. Graafland, et al.
Publicado: (2025)

Characterizing Japanese older adults without dementia by amyloid PET status: A comparative study of amyloid‐positive and amyloid‐negative groups from Japanese trial‐ready cohort study
por: Saki Nakashima, et al.
Publicado: (2026)

Autonomic dysfunction and hypothalamic atrophy in frontotemporal dementia and primary psychiatric disorders
por: Yannick S. S. Timar, et al.
Publicado: (2026)

Subjective memory concerns and AD/ADRD plasma biomarker associations in HABS‐HD
por: Kelsey R. Thomas, et al.
Publicado: (2026)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
por: Rachel R. Jin, et al.
Publicado: (2025)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
por: Darren M. Lipnicki, et al.
Publicado: (2026)

Reduced plasma hexosylceramides in frontotemporal dementia are a biomarker of white matter integrity
por: Oana C. Marian, et al.
Publicado: (2025)

Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
por: Emily K. Schworer, et al.
Publicado: (2024)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
por: Alexandra Paget‐Blanc, et al.
Publicado: (2025)

Risk prediction of mild cognitive impairment using electronic health record data
por: Gang Li, et al.
Publicado: (2025)

Association between BrainAGE and Alzheimer's disease biomarkers
por: Yousaf Abughofah, et al.
Publicado: (2025)

Proteomic profiling identifies serpin G1, ApoA‐II, and LBP as potential biomarkers of dementia in an Egyptian cohort
por: Shimaa A. Heikal, et al.
Publicado: (2025)

Prodromal Alzheimer's disease can affect activities of daily living for adults with Down syndrome
por: Tracy A. Listwan, et al.
Publicado: (2024)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
por: Sofia Toniolo, et al.
Publicado: (2024)

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
por: Russell Banks, et al.
Publicado: (2024)

Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
por: Andrée‐Ann Baril, et al.
Publicado: (2024)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
por: Faheem Arshad, et al.
Publicado: (2025)